APA

Sun B., Wang G., Liu H., Liu P., Twal W. O., Cheung H., Carroll S. L., Ethier S. P., Mevers E. E., Clardy J., Roberts T., Chen C., Li Q., Wang L., Yang M., Zhao J. J. & Wang Q. (2018). Oridonin inhibits aberrant AKT activation in breast cancer. : Oncotarget.

Chicago

Sun Bowen, Wang Geng, Liu Huidong, Liu Pian, Twal Waleed O, Cheung Hiuwing, Carroll Steven L, Ethier Stephen P, Mevers Emily E, Clardy Jon, Roberts Thomas, Chen Changbin, Li Qian, Wang Lanfeng, Yang Meixiang, Zhao Jean J and Wang Qi. 2018. Oridonin inhibits aberrant AKT activation in breast cancer. : Oncotarget.

Harvard

Sun B., Wang G., Liu H., Liu P., Twal W. O., Cheung H., Carroll S. L., Ethier S. P., Mevers E. E., Clardy J., Roberts T., Chen C., Li Q., Wang L., Yang M., Zhao J. J. and Wang Q. (2018). Oridonin inhibits aberrant AKT activation in breast cancer. : Oncotarget.

MLA

Sun Bowen, Wang Geng, Liu Huidong, Liu Pian, Twal Waleed O, Cheung Hiuwing, Carroll Steven L, Ethier Stephen P, Mevers Emily E, Clardy Jon, Roberts Thomas, Chen Changbin, Li Qian, Wang Lanfeng, Yang Meixiang, Zhao Jean J and Wang Qi. Oridonin inhibits aberrant AKT activation in breast cancer. : Oncotarget. 2018.